Terry Rabbitts

17PUBLICATIONS
93CO-AUTHORS
Molecular targetsHaematological tumoursImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 21, 2026
Correction: Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis.

|Dec 12, 2025
Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis.

Naphannop Sereesongsaeng, Carole Bataille, Angela Russell

|Jul 29, 2023
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation.

Cristiana Barone, Roberto Orsenigo, Anna Cazzola

|Mar 28, 2023
Intracellular Antibodies for Drug Discovery and as Drugs of the Future.

T H Rabbitts

|Nov 09, 2022
Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis.

Shaheen S Sikandar, Gunsagar S Gulati, Jane Antony

|Jan 12, 2022
Immunopolymer Lipid Nanoparticles for Delivery of Macromolecules to Antigen-Expressing Cells.

Arvind K Jain, Carole J R Bataille, Sabine Milhas

Pageof 3

Frequent Collaborators

7 joint publications

Nicolas Bery

2 joint publications

Fernando J Sialana

1 joint publications

Shamit Shrivastava

1 joint publications

Cristina Mecucci